Accurate risk assessment in coronary artery disease is very much needed in decreasing cardiovascular events through more appropriate targeting of preventive measures. Needless to say that high risk patients (those with [20% 10-year risk of future cardiovascular event) need more aggressive preventive therapy anyway. However, a majority of cardiovascular events occur in individuals at intermediate risk, i.e., a 10-20% 10-year risk. Consequently, cardiac risk assessment is mostly warranted in asymptomatic patients, particularly in those at intermediate risk. It has been suggested that traditional risk assessment may be refined with the selective use of newer imaging methods, such as coronary artery calcium scoring and noninvasive angiography with computed tomography (CT) techniques [1] [2] [3] [4] [5] [6] . These technologies, which allow quantification of atherosclerotic burden, can predict risk of cardiac events and might provide an approach to more widespread coronary atherosclerosis screening [7] .
Coronary calcification is a marker of atherosclerosis that can be quantified with the use of cardiac CT and it is proportional to the extent and severity of atherosclerotic disease. Because of the noninvasive nature of CT and the large societal burden of coronary atherosclerosis, there is great interest in developing CT-based techniques for detection of coronary artery calcium, a known marker of underlying atherosclerosis. However, important questions remain including the role of calcium in the process of acute plaque rupture [8] , the utility of this technique both the asymptomatic and symptomatic population [9] , and the statistical distribution of calcium scores and hard cardiac events in the general population [10] .
Sofar, the published studies demonstrate a high sensitivity of coronary artery calcium for the presence of coronary artery disease but a lower specificity for obstructive CAD depending on the magnitude of the coronary artery calcium. Several large clinical trials found true incremental predictive value of coronary artery calcium over the Framingham risk score when used in asymptomatic patients [10] . Based on multiple observational studies, patients with increased plaque burden (increased coronary artery calcium) are approximately 10 times more likely to suffer a cardiac event over the next 3-5 years [11] . Coronary calcium scores have outperformed conventional risk factors, highly sensitive Creactive protein (CRP), apolipoproteins [12] , and carotid intima-media thickness as a predictor of cardiovascular events [13] . The relevant prognostic information may be used to initiate or intensify appropriate treatment strategies to slow the progression of atherosclerotic vascular disease. Current data suggests intermediate risk patients may benefit most from further risk stratification with cardiac CT, as coronary artery calcium testing is effective at identifying increased risk and in motivating effective behavioral changes. It has been shown that for both general and special populations a zero score excludes most clinically relevant coronary artery disease. Budoff et al.
[10] showed a 10-year survival (after adjustment for risk factors, including age) of 99.4% for a calcium score of 0 which worsened to 87.8% for a score of[1,000. However, it should be realized that absence of coronary calcium does not completely eliminate the possibility of flow-limiting coronary artery disease. Importantly, a stepwise increase occurs in the risk of adverse events with increasing calcium scores in patients with and without ischemia on PET myocardial perfusion imaging [14] . On the other side of the spectrum, high calcium scores do not confer an increased risk for cardiac events among patients with normal scintigraphic myocardial perfusion studies [15] . Although, patients with increased calcium scores may be considered for intensive medical therapy to prevent future coronary artery disease events, a normal perfusion study in such patients suggests no need for more aggressive interventions. Nevertheless, there is nowadays sufficient evidence that coronary artery calcium may be considered as useful predictor of coronary artery disease in certain population of patients such as patients with diabetes, hypertension, and in elderly patients [16] [17] [18] [19] [20] [21] [22] [23] [24] .
In 2007, a clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain has been published [25] . This document consists of a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/ AHA). In this consensus document, the role of coronary calcium quantification is evaluated in identifying risk in asymptomatic patients, symptomatic patients, and selected subgroups such as women, ethnic groups, elderly patients, and patients with diabetes. Sequential to this document, a Task force on training in advanced cardiovascular imaging has recently been published with emphasis on training in cardiac CT [26] .
In the current issue of this journal, new recommendations provided by the European Society of Cardiac Radiology (ESCR) and North American Society for Cardiovascular Imaging (NASCI) are published [27] . In this extensive and interesting document the existing guidelines and the most relevant literature (142 references!) on coronary calcium screening for cardiac risk assessment are reviewed for both general and special populations. The coronary calcium score remains a strong predictor of incident coronary heart disease and provides predictive information beyond that provided by standard risk factors. For both general and special populations a zero score excludes most clinically relevant coronary artery disease. Regarding impact on therapy, it is clearly stated that there is currently still little evidence to alter prescription based on knowledge of the calcium score. Along those lines, the evidence is inconclusive as to the most accurate method to define progression of coronary artery calcium, putting into question the value of serial testing. Finally, the document addresses the importance of standardization of coronary artery calcium measurements by multi-detector CT.
To summarize, the new recommendations provide a wealth of useful information on the value of coronary artery calcium screening in patients suspected for and known with coronary artery disease. Therefore, this document deserves to be adopted by the European cardiology community.
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